Therefore, EphA2 binders can inhibit cancer cells’ growth blocking EphA2 activity both by the means of its degradation (agonist binders) and by the means of the inhibition of Eph–ephrin interactions (antagonist binders). The gene discussed is EPHA2; the disease is cancer.